ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damage.

Cell Death Dis · 2020 · PMC7367829 · PMID 32681017

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Our discovery of rs3214447 variant in relation to its negative impact on ECRG2 promoter activity is highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.